- Home
- GAME vs ASBP Comparison
GAME vs ASBP Comparison
Compare GAME & ASBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GAME
- ASBP
- Stock Information
- Founded
- GAME 2011
- ASBP 2021
- Country
- GAME United States
- ASBP United States
- Employees
- GAME N/A
- ASBP N/A
- Industry
- GAME
- ASBP Biotechnology: Pharmaceutical Preparations
- Sector
- GAME
- ASBP Health Care
- Exchange
- GAME Nasdaq
- ASBP Nasdaq
- Market Cap
- GAME 25.8M
- ASBP 26.6M
- IPO Year
- GAME 2009
- ASBP N/A
- Fundamental
- Price
- GAME $0.62
- ASBP $0.52
- Analyst Decision
- GAME Strong Buy
- ASBP
- Analyst Count
- GAME 3
- ASBP 0
- Target Price
- GAME $3.67
- ASBP N/A
- AVG Volume (30 Days)
- GAME 197.5K
- ASBP 1.1M
- Earning Date
- GAME 05-19-2025
- ASBP 05-24-2025
- Dividend Yield
- GAME N/A
- ASBP N/A
- EPS Growth
- GAME N/A
- ASBP N/A
- EPS
- GAME N/A
- ASBP N/A
- Revenue
- GAME $99,072,646.00
- ASBP N/A
- Revenue This Year
- GAME $102.01
- ASBP N/A
- Revenue Next Year
- GAME $17.88
- ASBP N/A
- P/E Ratio
- GAME N/A
- ASBP N/A
- Revenue Growth
- GAME 210.51
- ASBP N/A
- 52 Week Low
- GAME $0.50
- ASBP $0.40
- 52 Week High
- GAME $2.25
- ASBP $15.80
- Technical
- Relative Strength Index (RSI)
- GAME 44.31
- ASBP N/A
- Support Level
- GAME $0.56
- ASBP N/A
- Resistance Level
- GAME $0.69
- ASBP N/A
- Average True Range (ATR)
- GAME 0.08
- ASBP 0.00
- MACD
- GAME 0.00
- ASBP 0.00
- Stochastic Oscillator
- GAME 39.35
- ASBP 0.00
About GAME GameSquare Holdings Inc.
GameSquare Holdings Inc is engaged to revolutionize the way brands and game publishers connect with hard-to-reach Gen Z, Gen Alpha, and Millennial audiences. Its next generation media, entertainment, and technology help creators and maximize its brand partners return on investment. Its purpose-built platform, provide marketing and creative services, offer data and analytics solutions, and amplify awareness through FaZe Clan.
About ASBP Aspire Biopharma Holdings Inc. Common Stock
Aspire Biopharma Holdings Inc developing next-generation absorption of medicine that will have an impact on the opioid crisis. The group engaged in the business of developing and marketing disruptive technology for novel delivery mechanisms for do-no-harm drugs. Its nanotechnology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tract.